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A commentary on
Commentary: Arnica montana Effects on Gene Expression in a Human Macrophage Cell Line. 
Evaluation by Quantitative Real-Time PCR
by Chirumbolo S, Bjørklund G. Front Immunol (2016) 7:280. doi: 10.3389/fimmu.2016.00280
We recently investigated the effects of Arnica montana (Arnica) on the THP-1 myelomonocytic cell 
line, differentiated by phorbol-myristate acetate and IL-4 in the wound healing phenotype (M2) 
(1). Our study was the object of a commentary by Chirumbolo and Bjørklund (2), based on some 
recalculations and on their extrapolations from the values of SEM. Even though we had correctly 
reported the dosage of sesquiterpenes – reference substances for Arnica pharmacopeia – the authors 
inferred that this information was insufficient and they recalculated the doses in terms of helenalin: 
“in the starting 30% alcoholic preparation of Arnica (1c), a percentage of 0.036% sesquiterpene 
lactones, should correspond to 0.72 μg, i.e., 72  ng in the dilution 2c.” This calculation is flawed 
because our dose was referred to the mother tincture and not to the 1c dilution. Moreover, helenalin 
is not the only active ingredient in Arnica, which contains many other substances (3, 4). Finally, 
0.72 μg in 1c are not 72 ng in 2c but 7.2 ng.
Since a cellular target of helenalin is NF-κB, the authors argue that we did not show any effect 
“despite the existence of further reports published elsewhere showing an effect of sesquiterpene 
lactones on NF-κB.” Actually, it is true that we found little effect on NF-κB gene expression, but the 
cited effects of helenalin (2) reported elsewhere were not due to gene downregulation but to the 
inhibition of protein (that we did not test). The authors then proceed to evince skepticism that our 
results were obtained “in dilutions with active principles very far from a pharmacological bioactivity 
and without an apparent dose–response behaviour.” However, data that do not fall within linear 
dose–response relationships are not at all uncommon in pharmacology and immunology, and they 
result from various possible causes (5).
In the central part of the commentary (2), Chirumbolo and Bjørklund state that “showing only 
SEM or other parameters excluding raw data cannot allow the reader to realize about any statistical 
reliability and reproducibility.” Then, they claim to have “evaluated statistic distribution of SEM vari-
ability to ascertain if any reported outliers due to bias error affected the behaviour of the investigated 
samples.” The inherent contradiction in these two statements is easy to detect.
The authors do not have access to the original dataset, which – as almost always happens in 
scientific articles – was not reported by Olioso et al. (1) In fact, they only saw the exploratory statistics 
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tables from which they tried to extrapolate the distribution of 
the values of SEM, by pretending to find outliers there. Well, 
this procedure is actually an outlier in statistical practice! The 
different values of SEM are clearly not a sample of observations, 
and each of them refers to a different gene from cells in differ-
ent conditions, so studying the distribution of SEM values is 
totally meaningless. When working with small samples (here we 
have sizes from n = 6 to 10), an observation can be considered 
as an outlier only when it is greatly divergent from the others. 
According to the Dixon Q-test, the distance between the observa-
tion itself and the nearest one has to be equal or larger than one 
half of the total range. This would become apparent immediately 
just by reading the data carefully, and it should go without saying 
that such a check has been carried out on the dataset: in fact, for 
each treatment we checked the statistical homogeneity, the global 
comparison by means of ANOVA, the level of skewness, and the 
result of the T-test (see Methods) (1).
The commentary (2) contends that we “did not report repro-
ducible data for the highest concentrated dilution used in their 
study, i.e., Arnica 2c, which appeared to exhibit a significant 
action quite only on THP-1 cell line following activation with 
IL-4.” This concept is misleading because our cells were pro-
foundly changed by IL-4 treatment as shown by marker genes and 
the better effects of Arnica in these cells was a key finding of our 
investigation. So, looking for “reproducibility” in different cell 
types, as they have tried with a “linear regression” between M0 
with M2 macrophages in their figure 1 (2), is misrepresentative 
of our approach.
Some sentences (2) are beyond any understanding: “Probably, 
cells undergoing less stress (24 h incubation at 37°C 5% CO2) and 
addressed to drive any molecular machinery to a highly controlled 
response to a stimulus (i.e., IL-4) amplified signals vs. noises, i.e., 
reduced the difference between noises and statistical variability.” 
Equally, vague is the phrase “intra-assay and inter-assay variability, 
expressed as SEM, contained possible bias due to the dispersion 
effect of the reported variability and outlying data.” It is not clear 
how the authors can presume that the data variability could contain 
“bias.” The existence of genes with different stability is well known 
to experts on molecular biology and specifically on gene expres-
sion. We reported that even housekeeping genes have different 
variability (1). In any case, the fact that some macrophage genes in 
some conditions were characterized by a high experimental vari-
ability is not surprising, because the size of the effect was generally 
small, probably due to the low dose of the drugs used. Moreover, 
it is quite strange that the authors (2) have some doubts about the 
correct use of a non-parametric test (Wilcoxon test, specifically); it 
should be definitively undisputed that, when working with skewed 
data, it is not possible to apply standard parametric tests.
We agree that by replicating the data, one could better appre-
ciate the effects of Arnica on inflammatory gene upregulation. 
The whole field of high-dilution pharmacology needs further 
investigative efforts and experimental contributions; however, 
this certainly does not constitute a criticism of our work. Our 
findings provided a first albeit preliminary molecular explanation 
for the effects of Arnica on macrophages.
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